Details:

Alternative Title:
MMWR. Morbidity and mortality weekly report
Corporate Authors:
United States. Advisory Committee on Immunization Practices. ; American Academy of Family Physicians. ; American Academy of Pediatrics.
United States. Advisory Committee on Immunization Practices. ; American Academy of Family Physicians. ; American Academy of Pediatrics. Less -
Description:
On December 13, 2007, certain lots of Haemophilus influenzae type b (Hib) vaccine marketed as PedvaxHIB (monovalent Hib vaccine) and Comvax (Hib-HepB vaccine), and manufactured by Merck & Co., Inc., were recalled voluntarily, and the company temporarily suspended production of these vaccines. To conserve the limited supply of Hib-containing vaccines, CDC, in consultation with the Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians (AAFP), and the American Academy of Pediatrics (AAP), on December 18, 2007, recommended that vaccination providers temporarily defer the routine Hib vaccine booster dose administered to most healthy children at age 12-15 months
Subject:
[+]
Drug And Narcotic Control
Haemophilus Infections
Haemophilus Influenzae Type B
Haemophilus Vaccines
Humans
Immunization, Secondary
Immunization Schedule
Infant

Source:
MMWR. Morbidity and mortality weekly report. 2009; 58(24):673-4.
Pubmed ID:
19553904
Document Type:
Journal Issue
Place as Subject:
United States
Collection(s):
Guidelines and Recommendations
Advisory Committee on Immunization Practices (ACIP)
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:76e380e3055d40c2edda2f9fdbf8f04e3cf8a6dd862a7efa8321e532887a799c
File Type:

Supporting Files

• No Additional Files

More +